Formidable Asset Management

Formidable Asset Management is an investment firm that focuses on managing assets to achieve optimal financial returns for its clients. By employing a disciplined investment approach, the firm aims to identify and capitalize on diverse investment opportunities across various sectors. Dedicated to client-centric strategies, Formidable Asset Management seeks to align its investment decisions with the specific financial goals and risk tolerances of its clientele, ensuring a tailored approach to wealth management. The firm is committed to maintaining a high standard of integrity and transparency in all its operations, fostering long-term relationships with investors.

William Brown

Founder, CEO and Managing Partner

Adam Eagleston

Chief Investment Officer

2 past transactions

Owl's Brew

Series A in 2021
Owl's Brew, founded in 2013 by tea sommelier Jennie Ripps and Maria Littlefield, specializes in all-natural tea products crafted in New York City. The company offers two main product lines: Owl's Brew Mixer, which features tea-based craft cocktail mixers, and Owl's Brew Boozy Tea. Their beverages are made from whole tea leaves, fruits, spices, and herbs, ensuring that no added or artificial flavors are included. This commitment to quality allows consumers to enjoy a diverse range of flavored tea products that emphasize freshness and natural ingredients.

Imbed Biosciences

Series A in 2019
Imbed Biosciences, Inc. is a medical device company specializing in advanced technologies for integrating bioactive molecules into wound dressings and surgical implants. Founded in 2010 and based in Madison, Wisconsin, the company has developed antibacterial silver nanofilms that enable biologic dressings to release non-toxic silver over extended periods, effectively preventing infections in wounds. This innovation is aimed at improving wound management and expediting healing, addressing a significant market opportunity in the U.S. and Europe valued at $3 billion. As a spin-off from the University of Wisconsin-Madison, Imbed combines expertise from engineers, veterinary scientists, and medical surgeons, collectively bringing over 25 years of experience in clinical wound management. The company’s focus on antimicrobial wound matrices supports medical practitioners in treating complex wounds, ultimately enhancing patient care and outcomes.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.